William P Katt
7PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Aug 12, 2024
Distinct conformational states enable transglutaminase 2 to promote cancer cell survival versus cell death.Cody Aplin, Kara A Zielinski, Suzette Pabit
|May 15, 2024
Opportunities for targeted therapies: trametinib as a therapeutic approach to canine oral squamous cell carcinomas.Santiago Peralta, William Katt, Cheryl Balkman
|Feb 19, 2024
Defining the conformational states that enable transglutaminase 2 to promote cancer cell survival versus cell death.Cody Aplin, Kara A Zielinski, Suzette Pabit
|Oct 09, 2023
Inhibiting Glutamine Metabolism Blocks Coronavirus Replication in Mammalian Cells.Kai Su Greene, Annette Choi, Matthew Chen
|Apr 03, 2023
Alone and together: current approaches to targeting glutaminase enzymes as part of anti-cancer therapies.Thuy-Tien T Nguyen, William P Katt, Richard A Cerione
|Mar 28, 2022
Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives.William P Katt, Cody Aplin, Richard A Cerione
Pageof 2
Frequent Collaborators
3 joint publications
Richard Cerione
2 joint publications
Cody Aplin
2 joint publications
Kara A Zielinski
2 joint publications
Lois Pollack
1 joint publications
Santiago Peralta
1 joint publications
Elizabeth Moore
1 joint publications
Andrew White
1 joint publications
Thuy-Tien T Nguyen
1 joint publications
Kai Su Greene
1 joint publications
Suzette Pabit
